SF
AMRX icon

Synovus Financial’s Amneal Pharmaceuticals AMRX Stock Holding History

Synovus Financial’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,222
Closed -$43.1K – 825
2023
Q3 		$43.1K Hold
10,222
– – ﹤0.01% 831
2023
Q2 		$31.7K Hold
10,222
– – ﹤0.01% 833
2023
Q1 		$14.2K Hold
10,222
– – ﹤0.01% 823
2022
Q4 		$20.3K Sell
10,222
-5,000
-33% -$11.2K ﹤0.01% 853
2022
Q3 		$31K Hold
15,222
– – ﹤0.01% 836
2022
Q2 		$48K Hold
15,222
– – ﹤0.01% 832
2022
Q1 		$63K Hold
15,222
– – ﹤0.01% 835
2021
Q4 		$73K Hold
15,222
– – ﹤0.01% 849
2021
Q3 		$81K Hold
15,222
– – ﹤0.01% 828
2021
Q2 		$78K Buy
+15,222
New +$86.5K ﹤0.01% 826

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Synovus Financial's AMRX Position: Q4 2023 in Review

Synovus Financial sold out of Amneal Pharmaceuticals (AMRX) in Q4 2023, closing a stake of 10,222 shares — an estimated $43.1K sold.

Synovus Financial first reported a position in AMRX in Q2 2021 and held it in 10 quarters. The position peaked at $81K in Q3 2021. 153 funds tracked by Wall St. Rank hold AMRX as of Q4 2023.

  • Synovus Financial reported no remaining Amneal Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Synovus Financial sold 10,222 Amneal Pharmaceuticals shares in Q4 2023, an estimated $43.1K.
  • Synovus Financial first reported a position in Amneal Pharmaceuticals in Q2 2021 and held it in 10 quarters.
  • Synovus Financial's Amneal Pharmaceuticals position peaked at $81K in Q3 2021.
  • 153 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2023.

Based on Synovus Financial's 13F filing for Q4 2023, filed 14 Feb 2024.